Maternal Anti-Ro Antibody Titers Obtained with Commercially Available Immunoassays are Strongly Associated with Immune-Mediated Fetal Heart Disease.
Edgar T JaeggiVathany KulasingamJack ChenChun-Po Steve FanCarl LaskinRobert M HamiltonLinda T HirakiEarl D SilvermanLusia SepiashviliPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2023)
CNL is associated with substantially higher anti-Ro antibody titers than are obtained with a standard CIA. Enhancing the assay measuring range allows an improved specificity of identifying at-risk pregnancies of CNL. This article is protected by copyright. All rights reserved.